HM
Himal Mahipat Shah
About Himal Mahipat Shah
Data last updated:
Himal Mahipat Shah is a Designated Partner at Qure Hematology And Oncology Center Llp (since 2023). The company operates in Healthcare.
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Designated Partner | 01 Oct 2023 | 2018 | Active |
Board colleagues of Himal Mahipat Shah
| Name | DIN | Company | Designation |
|---|---|---|---|
| Ankit Dhirajlal Raiyani | 09354904 | Qure Hematology And Oncology Center Llp | Designated Partner |
| Eva Amit Vyas | 02152095 | Qure Hematology And Oncology Center Llp | Designated Partner |
| Jwalant Sureshbhai Shah | 02644030 | Qure Hematology And Oncology Center Llp | Designated Partner |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Himal Mahipat Shah
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Himal Mahipat Shah
Himal Mahipat Shah currently holds 1 directorship: Qure Hematology And Oncology Center Llp (Designated Partner, since 01 Oct 2023).
Himal Mahipat Shah was first appointed on 01 Oct 2023 as Designated Partner at Qure Hematology And Oncology Center Llp.
The current boards of Himal Mahipat Shah's companies include Ankit Dhirajlal Raiyani (Qure Hematology And Oncology Center Llp), Eva Amit Vyas (Qure Hematology And Oncology Center Llp), Jwalant Sureshbhai Shah (Qure Hematology And Oncology Center Llp).